Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]

Atezolizumab, obinutuzumab and venetoclax combination is active and leads to...

Prof Anna Maria Frustaci - Niguarda Ca’ Granda Hospital, Milan, Italy

Atezolizumab, obinutuzumab and venetoclax combination is active and leads to durable remissions in previously untreated DLBCL-RS ( Prof Anna Maria Frustaci - Niguarda Ca’ Granda Hospital, Milan, Italy )

Addition of blinatumomab to mini-hyper-CVD and inotuzumab improves outcomes in...

Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA

Addition of blinatumomab to mini-hyper-CVD and inotuzumab improves outcomes in R/R ALL ( Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA )

Chemotherapy-free combination of ponatinib and blinatumomab results in high...

Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA

Chemotherapy-free combination of ponatinib and blinatumomab results in high rates of CMR and NGS MRD negativity in Ph positive ALL ( Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA )

Ponatinib superior to imatinib in combination with reduced-intensity...

Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA

Ponatinib superior to imatinib in combination with reduced-intensity chemotherapy in newly diagnosed Ph positive ALL ( Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA )

Efficacy and safety of belantamab mafodotin vs pomalidomide plus dexamethasone...

Prof Meletios Dimopoulos - National and Kapodistrian University of Athens...

$Efficacy and safety of belantamab mafodotin vs pomalidomide plus dexamethasone in relapsed/refractory multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )$

Belamaf monotherapy induced rapid responses without unexpected toxicity in...

Dr Efstathios Kastritis - National and Kapodistrian University of Athens...

$Belamaf monotherapy induced rapid responses without unexpected toxicity in relapsed or refractory light chain amyloidosis ( Dr Efstathios Kastritis - National and Kapodistrian University of Athens, Athens, Greece )$

Triplets for newly diagnosed unfit AML patients could be feasible with...

Dr Juan Miguel Bergua Burgues - Hospital San Pedro de Alcántara, Cáceres, Spain

Triplets for newly diagnosed unfit AML patients could be feasible with substantial venetoclax reduction ( Dr Juan Miguel Bergua Burgues - Hospital San Pedro de Alcántara, Cáceres, Spain )

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic...

Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City...

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer ( Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City, USA )

The parotid gland; an unusual site of colorectal cancer metastasis

Dr Paula Isabel Franco - St Luke’s Medical Center, Malina, Philippines

The parotid gland; an unusual site of colorectal cancer metastasis ( Dr Paula Isabel Franco - St Luke’s Medical Center, Malina, Philippines )

ASCO's efforts to improve global cancer care through the years

Dr Carlos Santiago Vallejos Sologuren - Oncosalud, Lima, Peru

ASCO's efforts to improve global cancer care through the years ( Dr Carlos Santiago Vallejos Sologuren - Oncosalud, Lima, Peru )

US NCI's global health initiatives at ASCO 2023

Dr Satish Gopal - National Cancer Institute, Bethesda, USA

US NCI's global health initiatives at ASCO 2023 ( Dr Satish Gopal - National Cancer Institute, Bethesda, USA )

The Lancet Commission on Women and Cancer

Dr Ophira Ginsburg - National Cancer Institute, Bethesda, USA

The Lancet Commission on Women and Cancer ( Dr Ophira Ginsburg - National Cancer Institute, Bethesda, USA )

More from ecancer